Literature DB >> 7425598

Effects of sulfamethoxazole and trimethoprim on human neutrophil and lymphocyte functions in vitro: in vivo effects of co-trimoxazole.

R Anderson, G Grabow, R Oosthuizen, A Theron, A J Van Rensburg.   

Abstract

The effects of sulfamethoxazole and trimethoprim individually and in combination on in vitro neutrophil random migration, chemotaxis to autologous endotoxin-activated serum and the synthetic chemotactic tripeptide N-formyl-L-methionyl-L-leucyl-L-phenylalanine, phagocytosis and postphagocytic Nitro Blue Tetrazolium reduction, glycolysis, hexose monophosphate shunt activity, myeloperoxidase-mediated protein iodination, hydrogen peroxide production, and degranulation were assessed. The effects on lymphocyte mitogen-induced transformation were also evaluated. It was found that the test agents individually and in combination at high concentrations (> 100 microgram/ml) caused the inhibition of neutrophil postphagocytic myeloperoxidase-mediated protein iodination, which was related to the interference with H2O2 formation as the enzyme per se was unaffected. Both agents caused the inhibition of lymphocyte transformation at high concentrations (> 100 microgram/ml). In vivo studies before and after the ingestion of co-trimoxazole by three individuals showed no inhibition of any of the neutrophil functions tested. The inhibition of lymphocyte transformation was observed in one individual after the ingestion of the chemotherapeutic agent. These findings indicate that the concentrations which inhibit neutrophil H2O2 production and lymphocyte transformation in vitro are not attainable in vivo.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7425598      PMCID: PMC283784          DOI: 10.1128/AAC.17.3.322

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  A sensitive assay method for peroxidases from various sources.

Authors:  B B Paul; R J Selvaraj; A J Sbarra
Journal:  J Reticuloendothel Soc       Date:  1978-05

2.  Standardisation of the nitro-blue tetrazolium test and factors affecting its clinical application.

Authors:  R Sher; R Anderson; A R Rabson; H J Koornhof
Journal:  S Afr Med J       Date:  1974-02-09

3.  Immunosuppressive powers of the antibacterial agent trimethoprim.

Authors:  M W Ghilchik; A S Morris; D S Reeves
Journal:  Nature       Date:  1970-07-25       Impact factor: 49.962

4.  Immunosuppression by co-trimoxazole.

Authors:  H Arvilommi; M Vuori; A Salmi
Journal:  Br Med J       Date:  1972-09-23

5.  Trimethoprim, a sulphonamide potentiator.

Authors:  S R Bushby; G H Hitchings
Journal:  Br J Pharmacol Chemother       Date:  1968-05

6.  Sulphamethoxazole-trimethoprim: effect on antibody response in man.

Authors:  H Arvilommi; M Vuori; A Salmi
Journal:  Chemotherapy       Date:  1976       Impact factor: 2.544

7.  H2O2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and some regulating factors.

Authors:  R K Root; J Metcalf; N Oshino; B Chance
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

8.  Treatment of seven cases of chronic granulomatous disease with sulfamethoxazole-trimethoprim (SMX-TMP).

Authors:  Y Kobayashi; D Amano; K Ueda; Y Kagosaki; T Usui
Journal:  Eur J Pediatr       Date:  1978-04-20       Impact factor: 3.183

9.  Myeloperoxidase-mediated iodination by granulocytes. Intracellular site of operation and some regulating factors.

Authors:  R K Root; T P Stossel
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

10.  Suppression of thymidine uptake of human lymphocytes by co-trimoxazole.

Authors:  P M Gaylarde; I Sarkany
Journal:  Br Med J       Date:  1972-07-15
View more
  10 in total

1.  Antibiotic administration alleviates the aggravating effect of orthodontic force on ligature-induced experimental periodontitis bone loss in mice.

Authors:  J Shi; Z Liu; T Kawai; Y Zhou; X Han
Journal:  J Periodontal Res       Date:  2017-02-18       Impact factor: 4.419

2.  In vitro effect of cefodizime, imipenem/cilastatin and co-trimoxazole on dexamethasone and cyclosporin A depressed phagocytosis.

Authors:  A Dhondt; R Vanholder; M A Waterloos; G Glorieux; R De Smet; S Ringoir
Journal:  Infection       Date:  1998 Mar-Apr       Impact factor: 3.553

3.  Effects of moxalactam and cefuroxime on mitogen-stimulated human mononuclear leukocytes.

Authors:  J P Manzella; J K Clark
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

Review 4.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

5.  Effect of antimicrobial agents on human polymorphonuclear leukocyte microbicidal function.

Authors:  W D Welch; D Davis; L D Thrupp
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

6.  Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation.

Authors:  Claire D Bourke; Ethan K Gough; Godfrey Pimundu; Annie Shonhai; Chipo Berejena; Louise Terry; Lucas Baumard; Naheed Choudhry; Yusuf Karmali; Mutsa Bwakura-Dangarembizi; Victor Musiime; Joseph Lutaakome; Adeodata Kekitiinwa; Kuda Mutasa; Alexander J Szubert; Moira J Spyer; Jane R Deayton; Magdalena Glass; Hyun Min Geum; Claire Pardieu; Diana M Gibb; Nigel Klein; Thaddeus J Edens; A Sarah Walker; Amee R Manges; Andrew J Prendergast
Journal:  Sci Transl Med       Date:  2019-04-03       Impact factor: 17.956

7.  Efficacy of concurrent treatments in idiopathic pulmonary fibrosis patients with a rapid progression of respiratory failure: an analysis of a national administrative database in Japan.

Authors:  Keishi Oda; Kazuhiro Yatera; Yoshihisa Fujino; Hiroshi Ishimoto; Hiroyuki Nakao; Tetsuya Hanaka; Takaaki Ogoshi; Takashi Kido; Kiyohide Fushimi; Shinya Matsuda; Hiroshi Mukae
Journal:  BMC Pulm Med       Date:  2016-06-08       Impact factor: 3.317

8.  The Efficacy and Mechanism Evaluation of Treating Idiopathic Pulmonary fibrosis with the Addition of Co-trimoxazole (EME-TIPAC): study protocol for a randomised controlled trial.

Authors:  Matthew Hammond; Allan B Clark; Anthony P Cahn; Edwin R Chilvers; William Duncan Fraser; David M Livermore; Toby M Maher; Helen Parfrey; Ann Marie Swart; Susan Stirling; David Thickett; Moira Whyte; Andrew Wilson
Journal:  Trials       Date:  2018-02-05       Impact factor: 2.279

9.  Effect of Antiretroviral Therapy on HIV-mediated Impairment of the Neutrophil Antimycobacterial Response.

Authors:  David M Lowe; Nonzwakazi Bangani; Rene Goliath; Beate Kampmann; Katalin A Wilkinson; Robert J Wilkinson; Adrian R Martineau
Journal:  Ann Am Thorac Soc       Date:  2015-11

10.  Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis.

Authors:  Andrew J Prendergast; Mutsa Bwakura-Dangarembizi; Peter Mugyenyi; Joseph Lutaakome; Adeodata Kekitiinwa; Margaret J Thomason; Diana M Gibb; A Sarah Walker
Journal:  AIDS       Date:  2016-11-28       Impact factor: 4.177

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.